Smoking cessation strategies targeting specific populations

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations

Abstract

Quitting smoking helps smokers maintain their health and extend their lifespan by 10 or more years. Treatment strategies for smoking cessation should be tailored to individual smokers with special needs based on their specific circumstances. It is recommended that pregnant women adopt smoking cessation through counseling and behavioral interventions because the safety of medications has yet to be established. Counseling is the main strategy for smoking cessation in adolescents and nicotine replacement therapy can be used with caution in individuals with serious nicotine dependence. It is important for smokers with psychiatric diseases to quit smoking following accurate assessment of their depression status. Nicotine replacement therapy, varenicline, and bupropion can be used for smoking cessation in smokers with psychiatric disorders. The incidence of cardiovascular disease decreased according to the smoking status and the duration of smoking cessation. In smokers with chronic obstructive pulmonary disease (COPD) who used a combination of counseling and pharmacotherapy the quitting rate was more than twice as high as subjects who used behavioral interventions alone. Varenicline can be used as the most effective anti-smoking drug by most smokers including those with psychiatric disorders, cardiovascular disease, and COPD.

Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalTuberculosis and Respiratory Diseases
Volume82
Issue number1
DOIs
StatePublished - Jan 2019

Bibliographical note

Publisher Copyright:
© 2019 The Korean Academy of Tuberculosis and Respiratory Diseases.

Keywords

  • Pharmacotherapy
  • Population
  • Smoking cessation

Fingerprint

Dive into the research topics of 'Smoking cessation strategies targeting specific populations'. Together they form a unique fingerprint.

Cite this